메디
메디젠휴먼케어 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 대상웰라이프, was filed 23 Dec 2024.
메디젠휴먼케어: what insiders have been doing
메디젠휴먼케어 is a Health Care company. Its directors and officers file their transactions with DART (FSS). The past year has been quiet: not a single insider filing for 메디젠휴먼케어. The previous disclosure was published on 23 December 2024.
In the same sector, recent insider purchases at Relmada Therapeutics, Inc. and MAIA Biotechnology, Inc. also feature in our signals. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Insider Decl.
6
Thresholds
n/a
Buy Volume
n/a
4 ops. · all time
Sell Volume
n/a
n/a
Financial data
· cache
Last declaration on 23 December 2024
Declarations6 total
- 316,888 sharesKRXDART:20241223000174Canonical exit: 1 May 2023 (T+90)
- 0KRXDART:20240829000415
- 523 sharesShareKRXDART:20231019000141Canonical exit: 30 Oct 2022 (T+90)
- 0KRXDART:20231019000134
- 247,787 sharesShareKRXDART:20220318000129Canonical exit: 16 Jun 2022 (T+90)
- 247,787 sharesKRXDART:20220317001323Canonical exit: 15 Jun 2022 (T+90)
6 of 6 declarations
About 메디젠휴먼케어
Medigen Human Care is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for healthcare.
